Gateway Pharmacology

Chesterfield, United States Founded: 2012 • Age: 14 yrs Acquired By Inotiv
Preclinical CRO offering rodent models for evaluating safety and efficacy of drugs, mainly in 6 major disease areas
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products - Services tracked
Competitors 11 Brand Intelligence

About Gateway Pharmacology

Gateway Pharmacology is a company based in Chesterfield (United States) founded in 2012 was acquired by Inotiv in August 2021. Gateway Pharmacology operates in a competitive market with competitors including GenOway, TransCure bioServices, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

  • Headquarter Chesterfield, United States
  • Sectors
    Healthcare
  • Email
    Locked
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Healthcare Services & Infrastructure Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Inotiv

    (Aug 02, 2021)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Funding Insights of Gateway Pharmacology

Premium access

Detailed funding history for Gateway Pharmacology

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Gateway Pharmacology

Gateway Pharmacology has secured backing from 1 investor. Prominent investors backing the company include Inotiv Co.

All
Investor Description Founded Year Domain Location
Clinical development and regulatory services are provided by Inotiv.
Locked Locked Locked
Premium access

Investor details for Gateway Pharmacology

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Gateway Pharmacology

Investments
Premium access

Investment portfolio details for Gateway Pharmacology

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Gateway Pharmacology

Premium access

Detailed financials for Gateway Pharmacology

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Gateway Pharmacology Comparisons

Gateway Pharmacology Primary company
Description
Preclinical CRO offering rodent models for evaluating safety...
Location
Chesterfield, United States
Founded Year
2012
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Gateway Pharmacology

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Gateway Pharmacology

Gateway Pharmacology operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenOway, TransCure bioServices, PsychoGenics, PharmaLegacy Laboratories and InVivo Biosystems, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Provider of transgenic rodent models and customized cell lines for preclinical development
Locked Locked Locked
Humanized mouse models are developed for preclinical immune drug studies.
Locked Locked Locked
Preclinical CRO services for CNS and orphan disorders are offered.
Locked Locked Locked
Preclinical CRO offering in vivo models and services for a wide range of therapeutic areas
Locked Locked Locked
Animal models are supplied for in-vivo analytical services.
Locked Locked Locked
Preclinical contract research organization offering standard GLP and non-GLP services
Premium access

Detailed competitors of Gateway Pharmacology

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Gateway Pharmacology

Premium access

Complete news archive for Gateway Pharmacology

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gateway Pharmacology

Gateway Pharmacology was founded in 2012.

Gateway Pharmacology is headquartered in Chesterfield, United States. It is registered at Chesterfield, Missouri, United States.

Gateway Pharmacology was founded in 2012 in Chesterfield, United States, as a preclinical contract research organization. Services are delivered in three categories: disease pharmacology targeting hypertension, nephropathy, heart failure, fibrosis, metabolic diseases, and gastrointestinal disorders; safety pharmacology covering cardiac testing, renal function, and chronic infusions; and infusion pharmacology including PKPD studies, renal clearance, and biliary excretion. Operations occur in an AAALAC-accredited vivarium.

Gateway Pharmacology's top competitors include GenOway, PsychoGenics and Alpha Genesis.

Gateway Pharmacology has 1 investor. Key investors include Inotiv Co.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available